| Break-induced telomere synthesis underlies alternative telomere maintenance RL Dilley, P Verma, NW Cho, HD Winters, AR Wondisford, RA Greenberg Nature 539 (7627), 54, 2016 | 454 | 2016 |
| A PET imaging agent for evaluating PARP-1 expression in ovarian cancer M Makvandi, A Pantel, L Schwartz, E Schubert, K Xu, CJ Hsieh, C Hou, ... The Journal of clinical investigation 128 (5), 2116-2126, 2018 | 134 | 2018 |
| Sigma-2 Receptor/TMEM97 and PGRMC-1 Increase the Rate of Internalization of LDL by LDL Receptor through the Formation of a Ternary Complex A Riad, C Zeng, CC Weng, H Winters, K Xu, M Makvandi, T Metz, S Carlin, ... Scientific reports 8 (1), 16845, 2018 | 132 | 2018 |
| A Radiotracer Strategy to Quantify PARP-1 Expression In Vivo Provides a Biomarker That Can Enable Patient Selection for PARP Inhibitor Therapy M Makvandi, K Xu, BP Lieberman, RC Anderson, SS Effron, HD Winters, ... Cancer research 76 (15), 4516-4524, 2016 | 100 | 2016 |
| Host, pathogen, and environmental characteristics predict white-nose syndrome mortality in captive little brown myotis (Myotis lucifugus) JS Johnson, DAM Reeder, JW McMichael III, MB Meierhofer, DWF Stern, ... PLoS One 9 (11), e112502, 2014 | 78 | 2014 |
| Parp theranostic auger emitters are cytotoxic in brca mutant ovarian cancer and viable tumors from ovarian cancer patients enable ex-vivo screening of tumor response A Riad, SB Gitto, H Lee, HD Winters, PM Martorano, CJ Hsieh, K Xu, ... Molecules 25 (24), 6029, 2020 | 29 | 2020 |
| Prevalence of the amphibian chytrid fungus among zoo and pet store collections in the Northeastern United States HD Winters, KM Albertini, LE Neely, M Takahashi Herpetological Review 45 (2), 242, 2014 | 5 | 2014 |
| Use of Circulating Tumour DNA to Assess Minimal Residual Disease in Gastrointestinal Cancers R Mukherji, A Alqahtani, HD Winters, BA Weinberg touchREVIEWS in Oncology & Haematology 18 (1), 26-39, 2022 | 2 | 2022 |
| Microscopic residual disease (MRD) monitoring with circulating tumor DNA (ctDNA) across gastrointestinal (GI) malignancies. HD Winters, P Sackstein, BA Weinberg, D Debnath, X Geng, H Wang, ... Journal of Clinical Oncology 42 (3_suppl), 176-176, 2024 | | 2024 |
| Microscopic residual disease (MRD) monitoring and time to disease recurrence across gastrointestinal (GI) malignancies: A single-institution, real-world study. HD Winters, P Sackstein, BA Weinberg, D Debnath, X Geng, H Wang, ... Journal of Clinical Oncology 41 (16_suppl), e15518-e15518, 2023 | | 2023 |
| Tiptoeing on Metastatic Adenocarcinoma of the Lung A Kochar, HD Winters, L Zhang, B Zhang, K Thakur, R Essrani Case Reports in Oncological Medicine 2019 (1), 9302861, 2019 | | 2019 |
| PARP1 as a molecular target for the delivery of theranostic Auger emitters to cancer chromatin M MaKvandi, H Winters, CC Weng, L Puentes, CJ Hsieh, D Mankoff, ... Journal of Nuclear Medicine 59 (supplement 1), 59-59, 2018 | | 2018 |
| Abstract B086: Targeting Auger electrons to cellular nuclei via PARP-1 HD Winters, RH Mach, DA Mankoff, DA Pryma, M Makvandi Molecular Cancer Therapeutics 17 (1_Supplement), B086-B086, 2018 | | 2018 |
| Alternative Lengthening of Telomeres Requires a Specialized Replisome RL Dilley, P Verma, NW Cho, HD Winters, AR Wondisford Nat Med 22, 1303-13, 2016 | | 2016 |
| LVHN Scholarly Work s A Kochar, HD Winters, L Zhang, B Zhang, K Thakur | | |
